Vir Biotechnology Inc (VIR)
Interest coverage
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | -684,305 | -695,791 | -314,095 | -324,131 | 833,070 | 1,555,324 | 1,306,975 | 1,593,214 | 420,751 | -259,405 | -293,635 | -383,703 | -296,980 | -252,335 | -212,400 |
| Interest expense (ttm) | US$ in thousands | 478 | 9,959 | 19,291 | 39,180 | 39,329 | 29,609 | 20,277 | 388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest coverage | -1,431.60 | -69.87 | -16.28 | -8.27 | 21.18 | 52.53 | 64.46 | 4,106.22 | — | — | — | — | — | — | — |
December 31, 2023 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $-684,305K ÷ $478K
= -1,431.60
As the data for interest coverage ratio for Vir Biotechnology Inc is not provided for any of the quarters in the table, it is not possible to perform a detailed analysis of the company's ability to cover its interest expenses using this ratio. The interest coverage ratio is a crucial metric that indicates a company's ability to meet its interest payments on outstanding debt. A higher interest coverage ratio suggests that the company is more capable of meeting its interest obligations, while a lower ratio may indicate potential financial distress.
Without the specific values for the interest coverage ratio, it is challenging to assess Vir Biotechnology Inc's financial health in terms of its ability to service its interest payments. I recommend obtaining the necessary data to calculate the interest coverage ratio for each quarter to gain insights into the company's financial strength and debt repayment capacity.
Peer comparison
Dec 31, 2023